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A B S T R A C T
Sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly that is usually congenital, but may be
acquired. They are usually asymptomatic unless they compress adjacent structures, develop thrombosis,
or rupture. A ruptured SVA (RSVA) can lead to rapid hemodynamic deterioration and often needs to be
addressed emergently. Surgical correction has traditionally been the treatment of choice for RSVA;
however, lately they have been successfully closed percutaneously using various transcatheter devices.
Few cases of RSVA during pregnancy have been reported which were conservatively or surgically
managed. There is no documented case of transcatheter closure of RSVA during pregnancy. We report the
ﬁrst case of successful percutaneous device closure of RSVA using an Amplatzer duct occluder in a
pregnant woman presenting with heart failure due to RSVA at 26 weeks of gestation.
<Learning objective: Ruptured sinus of Valsalva aneurysm (RSVA) is traditionally repaired by surgery
but more recently amenable to percutaneous intervention. Management of RSVA during pregnancy is
complex and has been managed by surgery in the past incurring signiﬁcant risk to fetus due to effects of
cardiopulmonary bypass. We report a case of RSVA in pregnancy that was closed by transcatheter closure
for the ﬁrst time, thereby signiﬁcantly reducing maternal and fetal risks. While risks are present during
pregnancy, emergently indicated life-saving invasive cardiac procedures should not be denied solely on
the pregnant state.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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A sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly,
usually congenital in origin, rarely acquired, most often arising
from right coronary sinus (80.7%), less often from non-coronary
sinus (15.8%), and rarely from left (3.5%) sinus [1]. SVA are
asymptomatic unless they compress adjacent structures, form a
thrombus, or rupture causing left to right shunting or aortic valve
insufﬁciency and congestive heart failure that often requires
urgent surgical resolution. There are few documented cases of
ruptured SVA (RSVA) in pregnant patients some of whom were
managed by surgical repair [2] and for others intervention was
postponed until after delivery [3]. We present for the ﬁrst time, a
case of RSVA that was closed by transcatheter closure during
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A 25-year-old, 26-week pregnant primigravida weighing 58 kg
with a past history of small perimembranous ventricular septal
defect (VSD) was transferred to our center from an obstetric
hospital for evaluation and management of acute heart failure. On
examination, she was mildly dyspneic at rest (respiratory rate: 22/
min), tachycardic (heart rate: 120/min), and normotensive (BP:
110/60 mmHg). Her jugular venous pressure was elevated;
precordium was hyperdynamic with a prominent systolic and
diastolic thrill. S1 and S2 were normal; a diffuse grade 4/6
continuous murmur was heard. She had 3-cm hepatomegaly and
bilateral mild pitting pedal edema. She did not have any symptoms
or signs of connective tissue disorder. Electrocardiogram showed
normal sinus rhythm with infrequent premature ventricular
contractions. A transthoracic echocardiogram (TTE) revealed
mildly dilated left ventricle with normal function, a 7-mm
perimembranous ventricular septal defect (VSD), SVA of right
coronary sinus that had ruptured into the right ventricular outﬂow
tract (RVOT) through a 7-mm defect (Fig. 1, and see supplementary
data online, Video 1). Color Doppler revealed continuous ﬂow from reserved.
Fig. 1.
Transthoracic echocardiographic images in parasternal short-axis view demonstrating small perimembranous ventricular septal defect and ruptured aneurysm
of right coronary sinus of Valsalva with left to right shunt into the right ventricular outﬂow tract.
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pulmonary hypertension. There was no pericardial effusion.
Simultaneous ultrasound and fetal echocardiogram conﬁrmed
fetal well-being and absence of fetal cardiac defects. Her symptoms
of acute heart failure progressed and her hemodynamic condition
worsened overnight despite medical therapy, necessitating inter-
vention. After some consideration of surgical vs. catheter closure,
we decided to proceed with the percutaneous route, because the
latter procedure was safer for the mother and also carried less fetal
risk.
General anesthesia was avoided; the procedure was performed
under local anesthesia with TTE guidance after her abdomen was
properly shielded with lead. 7F short sheaths were secured in right
femoral vein and bilateral femoral arteries and heparin adminis-
tered. Aortic root angiogram was done which showed SVA from
right coronary sinus measuring 8 mm at its origin, with contrast
spilling into RVOT from the ruptured site (Fig. 2 and see
supplementary data online, Video 2). The coronary arteries
appeared normal. Antegrade approach was employed. Arterio-
venous loop was created by passing through the defect from the
aortic side using an angled tip 0.03500 glide wire (Terumo Inc.,
Tokyo, Japan) in 6F Judkins right coronary catheter. Glide wire was
exchanged with a 260 cm, 0.03500 Amplatz support stiff guide wire
(Cook Medical Inc., Bloomington, IN, USA) over which a 7F
Amplatzer long sheath (St. Jude Medical, Inc. St. Paul, MN, USA) was
tracked from the venous side and parked in ascending aorta. We
chose to use an Amplatzer Duct Occluder (ADO1; St. Jude Medical,
Inc.) because we thought it suited best for the ‘‘wind-sock’’-like
defect this patient had, with a broader aortic end. We chose to
oversize it to 4 mm greater (ADO 12/14) than the defect size
(8 mm) because the margins of this wind-sock-like defect
appeared ﬂimsy. The device was loaded over the cable, passedthrough the long sheath and deployed across the defect.
Angiogram performed via pigtail catheter introduced through
the second femoral arterial sheath conﬁrmed optimum position
and absence of residual shunt. After TTE revealed no impingement
of device on aortic leaﬂets and no change in degree of aortic
insufﬁciency, the device was released (Fig. 3 and see supplemen-
tary data online, Video 3). All pregnancy precautions, such as
keeping ﬂouroscopy time short (22 min), reducing number of
cineangiograms (6 at 15 fps), radiation dose (dose area product-
23,796 mGy cm2), and contrast volume were taken. Soon after the
procedure, the patient reported improvement in her symptoms;
clinically diastolic component of murmur disappeared (holosys-
tolic murmur of VSD persisted). TTE after the procedure revealed
the device to be in a good position without any residual shunt
(Fig. 4). Fetal echocardiography conﬁrmed an active fetus with
normal fetal heart rate and rhythm. We decided to follow the small
VSD medically as the shunt was not hemodynamically signiﬁcant
enough to close. Aspirin at 150 mg once daily was commenced,
which was continued throughout pregnancy. Mother and fetus
were regularly followed and elective cesarean section was
performed at near term to deliver a healthy 3-kg baby.
Discussion
Incidence of SVA ranges from 0.23% to 1.5%, being higher in
Asians [1]. Pathogenesis likely involves incomplete fusion of distal
bulbar septum and truncal ridges, leading to weakness between
aortic media and annulus ﬁbrosus resulting in aneurysmal
enlargement of sinus. SVA ruptures in 35% of cases, leading to
acute symptoms of dyspnea, palpitation, chest pain, and fatigue in
one fourth of the patients.
Fig. 3.
Post-procedure angiographic image in 308 right anterior oblique projection demonstrating a well seated Amplatzer Duct Occluder (ADO) I device across the
ruptured aneurysm of right coronary sinus of Valsalva (RSVA) without any residual shunt.
Fig. 2.
Angiographic image in 308 right anterior oblique projection demonstrating right coronary sinus of Valsalva aneurysm (SVA) and contrast spilling into right
ventricular outﬂow tract through the ruptured sinus (thick arrow), mouth of aneurysm measuring 8 mm (thin arrow).
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Fig. 4. Post-procedure transthoracic echocardiogram in parasternal long-axis view showing device in good position across the mouth of sinus of Valsalva aneurysm.
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pregnancy precipitates rupture. Increase in cardiac output and
decrease in systemic vascular resistance, during pregnancy, may
precipitate cardiac failure in patients with intracardiac shunts.
Pregnancy also causes hormonally induced change in mechanical
properties of connective tissue, which could theoretically lead to
rupture of SVA more often during pregnancy.
Management of RSVA during pregnancy can be challenging.
Most reported cases were followed conservatively until delivery
without intervention [3]. However, in patients such as ours who
present with progressive heart failure, deﬁnitive management
during pregnancy becomes imperative. Treatment of choice for
RSVA has traditionally been surgical correction [11]; however,
cardiac surgery with extra corporeal support in a pregnant patient
constitutes a complex task, as the sum effects of anesthesia,
surgery, and cardiopulmonary bypass (CPB) on two individuals
under biologically distinct situations have to be considered.
Hemodilution, changes in coagulation, complement activation,
release of vasoactive substances, particulate and air embolism,
and hypotension during CPB add to the deleterious effect of pre-
existing hyperdynamic circulation of pregnancy [12]. Emergent
CPB invariably causes fetal bradycardia, likely due to placental
hypoperfusion and hypoxia [12]. Non-pulsatile ﬂow of CPB
rapidly triggers severe placental dysfunction due to vasocon-
striction and catecholamine-mediated increase in systemic
vascular resistance both of which may cause fetal death
[12]. However, with improving anesthetic and surgical techni-
ques, risk to the mother has been reduced to levels similar to that
of non-pregnant counterparts; nonetheless, the fetal mortality
remains high (19–33%) [12,13]. We found only two reports of
surgical repair during pregnancy using CPB and deep hypother-
mic circulatory arrest who subsequently delivered normal
infants at term [2,14].
This is the ﬁrst report of successful transcatheter closure of
RSVA during pregnancy. Cardiac catheterization in pregnancy also
poses a unique challenge due to potential risks from radiation and
medication (acute and chronic) use. Exposure of pregnant womento radiation often causes high levels of anxiety, but it is reassuring
that the harmful effects of radiation such as spontaneous abortion,
carcinogenesis, genetic effects, and teratogenicity are typically not
observed with the doses used for the majority of diagnostic and
therapeutic procedures. Risk for the fetus is limited when the
exposure dose to the mother is <50 mGy and for most cardiac
procedures this usually does not exceed 20 mGy [15]. At these
doses there is no observed increased risk of fetal malformation; a
small increase in risk of childhood cancer cannot be excluded.
Effective doses to fetus of over 50–100 mSv are known to increase
the incidence of fetal malformation, while the median exposure of
fetus in most therapeutic cardiac catheterization procedures is
6.0 mSV [16]. Despite the low risk of radiation, all precautions
such as restricting the X-ray beam size, directing primary beam
away from the fetus, selecting appropriate exposure factors,
minimizing ﬂuoroscopy time, abdominal shielding, and minimiz-
ing iodinated contrast agents must be taken. The best period to
perform invasive procedures is the beginning of the second
trimester, when organogenesis is complete but the uterus is still
small. While risks are present during pregnancy, emergently
indicated invasive cardiac procedures should not be denied or
delayed solely on the pregnant state, as many of these procedures
have highly time-responsive beneﬁts that can be lost by irrational
delays.
Another issue that needs special address during pregnancy is
the safety to the fetus of long-term oral medications such as aspirin
to prevent device thrombosis. Oligohydramnios and minor
bleeding complications after delivery may occur with aspirin;
however, aspirin at 60–150 mg /day is widely used for prevention
of pregnancy-induced hypertension with no observed risk of
maternal or neonatal adverse effects [17]. There have been no
reports of premature closure of the fetal ductus arteriosus with the
maternal use of aspirin.
To conclude, transcatheter closure of RSVA is safe and effective
even during pregnancy. It can be life-saving for a pregnant woman
with this condition without incurring the high fetal morbidity and
mortality associated with maternal cardiac surgery using CPB. It is
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elderly, and those with co-morbidities who are considered at high
risk for cardiac surgery. Extended follow-up is required to assess
the long-term outcome of these patients.
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Supplementary data associated with this article can be found,
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